Somani to vet vaccine proposals, met for the second time this week, recommended emergency approval for Oxford-AstraZeneca COVID-19 vaccine. Dubbed as Covishield in India, the Oxford-AstraZeneca COVID-19 vaccine showed an average efficacy of 70.4%, with no hospitalisations or severe disease, according to the data. Serum Institute sought emergency use licence for a version of the British drugmaker’s vaccine in India last month. Britain last week approved the emergency authorisation of Oxford-AstraZeneca COVID-19 vaccine in the country. "The COVID-19 vaccine will be distributed initially in India, then we will look at the COVAX countries which are mainly in Africa.

Source: Mint January 01, 2021 11:05 UTC